Developmental population pharmacokinetics of caffeine in Chinese premature infants with apnoea of prematurity: A post‐marketing study to support paediatric labelling in China

• Published in: British journal of clinical pharmacology Vol. 87; no. 3; pp. 1155 - 1164
• Main Authors: Gao, Xiang‐Bo, Zheng, Yi, Yang, Fan, Wang, Chen‐Hong, Jiang, Zhou‐Hong, Wu, Yue‐E, Jacqz‐Aigrain, Evelyne, Ni, Shao‐Qing, Zhao, Wei
• Format: Journal Article
• Language: English
• Published: England 01.03.2021
• Subjects: apnoea of prematurity; Chinese premature infants; pharmacokinetics–pharmacogenetics; postmarketing study; pharmacokinetics-pharmacogenetics; Chinese premature infants; postmarketing study; apnoea of prematurity
• ISSN: 0306-5251; 1365-2125
• DOI: 10.1111/bcp.14483

Aims The aim of the study was to evaluate the suitability of the current caffeine dosing regimen for the Chinese population using modelling and simulation approach. Methods Pharmacokinetic samples were collected from 99 Chinese newborns with premature apnoea. The median (range) of gestational age and postmenstrual age were 28.3 (25.0–33.4) weeks and 31.1 (26.4–38.0) weeks, respectively. Newborns were receiving caffeine citrate at a loading dose of 20 mg/kg/d and a maintenance dose of 5–10 mg/kg/d. Caffeine concentrations and CYP1A2 polymorphisms were investigated. Population pharmacokinetic modelling of caffeine in Chinese preterm newborn on a population‐wide scale was conducted using NONMEM. Results A 1‐compartment model with first‐order elimination was used to describe population pharmacokinetic. With current weight implemented using 0.75 allometric scaling, clearance (CL) was positively related to current weight and postmenstrual age, but a negative relationship was observed with serum creatinine concentration. Eight genotypes of CYP1A2 were tested and none of them had a significant impact on caffeine pharmacokinetic parameters. Interindividual variability of CL and volume of distribution was 7.70 and 65.9%. The median (range) of 95% confidence intervals of CL were 0.0128 (0.0128–0.0131) L/h/kg. Monte Carlo simulation demonstrated that 80% (loading dose) and 98% (maintenance dose) of premature infants treated with a labelled dosing regimen attained the concentration target range of 5–20 mg/L. Conclusion A population PK model of caffeine was developed in Chinese newborns. Body weight‐implemented allometric scaling, postmenstrual age and serum creatinine concentration markedly affected caffeine clearance. The labelled dosing regimen is suitable for Chinese premature infants.